Literature DB >> 15301736

Role of gap junctions in endothelium-derived hyperpolarizing factor-mediated vasodilatation in rat renal artery.

Joanna Karagiannis1, Michael Rand, Chun-Guang Li.   

Abstract

AIM: To investigate the effects of gap junction inhibitors on endothelium-derived but nitric oxide (NO)- and prostacyclin (PGI2)-independent vasodilatations induced by carbachol in the rat isolated renal artery.
METHODS: Isolated renal arteries were mounted on a wire myograph apparatus were tissues treated with the nitric oxide synthase inhibitor Nomega-nitro-L-arginine methyl ester hydrochloride (NAME; 100 micromol/L) and indomethacin (10 micromol/L) and precontracted with phenylephrine (0.1 micromol/L). NAME and indomethacin treated carbachol (0.01-10 micromol/L)- or sodium nitroprusside (SNP; 1-300 nmol/L)-induced mediated relaxations were observed in the presence of gap junction inhibitors.
RESULTS: Carbachol produced a concentration-dependent relaxation in tissues treated with NAME (100 micromol/L) and indomethacin (10 micromol/L). This relaxation was not affected by hemoglobin (3 micromol/L), but was inhibited by charybdotoxin (200 nmol/L) and ouabain (30 micromol/L). The putative gap junction inhibitors, GAP 27 peptides with sequence homology to connexins 40 and 43 respectively reduced carbachol- but not SNP-induced relaxations mediated by endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxations. The inhibition by the connexin 43 inhibitor was greater than that of the connexin 40 inhibitor.
CONCLUSION: The results indicate the presence of gap junctions sensitive to 43GAP 27 and 40GAP 27 in the rat renal artery and each of these different types of gap junctions plays a role in the NO- and PGI2-independent relaxations induced by carbachol in this blood vessel. However, connexin 43 appears to play a more predominant role in mediating gap junction communications in the rat renal artery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15301736

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  7 in total

Review 1.  Connexins and the kidney.

Authors:  Fiona Hanner; Charlotte Mehlin Sorensen; Niels-Henrik Holstein-Rathlou; János Peti-Peterdi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-17       Impact factor: 3.619

Review 2.  Functional roles of connexins and pannexins in the kidney.

Authors:  Ahmed B Abed; Panagiotis Kavvadas; Christos E Chadjichristos
Journal:  Cell Mol Life Sci       Date:  2015-06-17       Impact factor: 9.261

Review 3.  Connexin and Pannexin Large-Pore Channels in Microcirculation and Neurovascular Coupling Function.

Authors:  Pía C Burboa; Mariela Puebla; Pablo S Gaete; Walter N Durán; Mauricio A Lillo
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

4.  Endogenous ouabain in hypertensive disorder complicating pregnancy.

Authors:  Li Wu; Chengliang Xiong; Ping Su
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-12

Review 5.  Connexins in vascular physiology and pathology.

Authors:  Anne C Brisset; Brant E Isakson; Brenda R Kwak
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

Review 6.  Gap junctions in the control of vascular function.

Authors:  Xavier F Figueroa; Brian R Duling
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

Review 7.  Targeting the Endothelium to Achieve Cardioprotection.

Authors:  Nicolas Herrera-Zelada; Ursula Zuñiga-Cuevas; Andres Ramirez-Reyes; Sergio Lavandero; Jaime A Riquelme
Journal:  Front Pharmacol       Date:  2021-02-02       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.